BioScience Health Innovations, Inc.
BHIC
$4.13
-$0.05-1.20%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -102.57% | 638.05% | 2,194.56% | 1,372.69% | 342.19% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -284.91% | -539.59% | -2,956.22% | -985.76% | -204.36% |
| Cash from Operations | -277.27% | 642.24% | 1,209.41% | 682.58% | 238.14% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 51.96% | -118.85% | -830.00% | -- | -- |
| Cash from Investing | 51.96% | -118.85% | -830.00% | -- | -- |
| Total Debt Issued | 142.87% | 216.38% | 183.54% | 127.28% | 70.70% |
| Total Debt Repaid | -113.37% | -195.05% | -151.54% | -99.82% | -55.57% |
| Issuance of Common Stock | -24.64% | -- | 40.00% | 81.25% | 31.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 43.91% | -117.94% | 130.69% | 179.46% | 58.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -87.52% | -100.09% | 176.85% | 917.17% | 1,020.24% |